| V00704 | |
|
|
|
| ¥39,357.00 | |
|
|
|
|
|
|
| Ask us a question | |
BNP and NT-proBNP are separated from precursor molecule proBNP via proteolytic processing. The BNP and NT-proBNP level in blood are proportional to the severity of cardiac dysfunction. They can be used for diagnosis of congestive heart failure (CHF). |
GenScript can customize this product per customer's request including product size, buffer components,etc.
| Subclass | Recombinant human IgG1 |
| Conjugation | Unconjugated |
| Antigen Species | Human |
| Production | Cultured in vitro under conditions free from animal-derived components |
| Purification | Protein A/G affinity column |
| Formulation |
1) PBS, pH 7.4, containing 0.03% Proclin 300 2) 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 * *: For new batch since 09/01/2018, please refer to COA. |
| Concentration | ≥2mg/ml |
| Clone ID | 3B42HC |
| Recommended pairs |
CLIA (Capture-Detection):
3B42HC - 22B11 TRFIA (Capture-Detection): 10B11 - 22B11 Sandwich immunoassay (Capture-Detection): 7C4 - 8D5 |
| Storage | For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. |
| CLIA/TRFIA/ELISA |
| Target Background | BNP and NT-proBNP are separated from precursor molecule proBNP via proteolytic processing. The BNP and NT-proBNP level in blood are proportional to the severity of cardiac dysfunction. They can be used for diagnosis of congestive heart failure (CHF). |
